Curcumin reduces renal damage associated with rhabdomyolysis by decreasing ferroptosis-mediated cell death
In a 2003 study on multiple sclerosis patients, ALCAR supplementation for six months significantly increased glutathione levels in cerebrospinal fluid and reduced oxidative stress markers
Maintenance is not about perfection
Peptide Degradation and Contamination Risk: BPC-157 sourced from unregulated research suppliers carries the risk of contamination, incorrect peptide sequencing, or degraded compound from improper storage, introducing unpredictable biological effects beyond the peptide's known pharmacology
The REWIND trial's cognitive substudy with dulaglutide and smaller trials of liraglutide in Alzheimer's disease have shown modest or inconsistent effects
Effectiveness In four clinical trials, people diagnosed as overweight or obese took Contrave for up to 56 weeks: In one of the four studies, 40% of participants who took Contrave lost at least 5% of their body weight, and 20% of participants lost at least 10%